InvestorsHub Logo
Followers 13
Posts 1547
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Thursday, 10/18/2018 5:04:35 AM

Thursday, October 18, 2018 5:04:35 AM

Post# of 34626
Another CAR-T gets bought for 2.1 Billion.
Novartis buying Endocyte and it's CAR-T adaptor molecule (CAM) tech.
ECYT was $2.24 a share when bought on 4/17/17.
I really don't like when giants buy the smaller company, I think they would wind up making more $ in the long run just staying themselves and growing themselves.
Merck, Celgene and AbbVie gobbled a few of mine already.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News